+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
EIKO EIKO

Eiko Lifesciences Share Price

₹45.38 -1.15 (-2.47%)
Near 52W Low of ₹44.75

04 Sep, 2026 4:01 PM (IST)

Eiko Lifesciences live price: ₹45.38. It opened at ₹47 vs previous close ₹47; intraday high/low: ₹47/₹45. The 50 & 200 DMA stand at ₹48.60/₹50.70.

Eiko Lifesciences Performance

  • Today's Low
  • ₹45
  • Today's High
  • ₹47
  • 52 Week Low
  • ₹45
  • 52 Week High
  • ₹64
  • Open Price₹47
  • Previous Close₹47
  • Volume12,894
  • 50 DMA₹48.60
  • 100 DMA₹49.60
  • 200 DMA₹50.70

Eiko Lifesciences Chart

Investment Returns

  • Over 1 Month -6.57%
  • Over 3 Month -9.09%
  • Over 6 Month -9.24%
  • Over 1 Year -11.61%

Smart Investing Starts Here Start SIP with Eiko Lifesciences for Steady Growth!

Invest Now

Eiko Lifesciences Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 12.7
  • PEG Ratio
  • 0.2
  • Market Cap Cr
  • 62
  • P/B Ratio
  • 0.9
  • Average True Range
  • 2
  • EPS
  • 3.6
  • Dividend Yield
  • 0
  • MACD Signal
  • -0.8
  • RSI
  • 36.65
  • MFI
  • 18.3

Latest Stock News Updates

Eiko Lifesciences Ltd - 540204 - Compliance Under Regulation 36 Of The SEBI (Listing Obligations And Disclosures Requirements) Regulations, 2015 ('The Listing Regulations')

The Company has sent a letter providing the weblink and QR Code for accessing the Notice convening the 49th Annual General Meeting ("AGM") and the Annual Report of the Company for the Financial Year 2025-26, to the following categories of shareholders: i. Shareholders who have not registered their email addresses with the Company, its Registrar and Share Transfer Agent ("RTA"), or the Depository Participants ("DPs"); ii. Shareholders who have registered their email addresses with the Company, its RTA, or the DPs, but to whom the Notice could not be delivered on account of an invalid email address; iii. Shareholders who have registered their email addresses with the Company, its RTA, or the DPs, but in whose case the intimation email regarding the AGM has bounced back and the Notice could therefore not be delivered; and iv. Shareholders holding equity shares of the Company in physical form.

Eiko Lifesciences Ltd - 540204 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Newspaper Advertisement for 49th Annual General Meeting (AGM) of the Company scheduled to be held on Tuesday, 22nd day of September, 2026 at 04:00 P.M. IST through Video Conference / Other Audio-Visual Means

Eiko Lifesciences Ltd - 540204 - Reg. 34 (1) Annual Report.

Pursuant to provision of Regulations 30 and 34 of the SEBI LODR Regulations, 2015, we wish to inform that the 49th Annual General Meeting of the Company will be held on Tuesday, 22nd day of September, 2026 at 04:00 P.M. (IST) through Video Conferencing/ Other Audio Visual Means. Please find enclosed the copy of the Annual Report of 49th AGM for the Financial Year 2025-26 of the Company. The 49th Annual Report is also being uploaded on the website of the Company at www.eikolifesciences.com. In compliance with the SEBI circulars, the Annual Report along with the Notice of the AGM is being sent only by electronic mode to those shareholders whose e-mail addresses are registered with the Company/ Registrar and Transfer Agent of the Company/Depository Participants. For those shareholders who have not registered their email ids, a letter providing a weblink from where the Notice of the AGM and Annual Report for the financial year 2025-26 can be accessed is being sent.

Eiko Lifesciences Financials

Eiko Lifesciences Technicals

EMA & SMA

Current Price
₹45.38
-1.15 (-2.47%)
pointer
  • Bearish Moving Average 16
  • Bullish Moving Average 0
  • 20 Day
  • ₹47.50
  • 50 Day
  • ₹48.60
  • 100 Day
  • ₹49.60
  • 200 Day
  • ₹50.70

Resistance and Support

45.83 Pivot Speed
  • R3 49.30
  • R2 48.30
  • R1 46.80
  • S1 44.40
  • S2 43.40
  • S3 41.90

Eiko Lifesciences Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-08-12 Quarterly Results
2026-05-26 Audited Results
2026-01-29 Quarterly Results
2025-12-11 Others Inter alia, To consider the proposal for raising of funds by way of issue of one or more of instruments comprising of Equity Shares, Convertible Securities through Private Placement/Preferential Issue
2025-10-31 Quarterly Results

Eiko Lifesciences Shareholding Pattern

60.09%
39.91%
0%

About Eiko Lifesciences

Eiko Lifesciences engaged in specialty chemicals and pharmaceutical intermediates sector, the Company is committed to conducting its business with the highest standards of integrity, ethical conduct, transparency and accountability. The governance framework of the Company is designed to ensure responsible decision-making, effective risk management, regulatory compliance and protection of stakeholder interests while fostering innovation, operational excellence and business sustainability. View More
  • NSE Symbol
  • EIKO
  • BSE Symbol
  • 540204
  • ISIN
  • INE666Q01016

Similar Stocks to Eiko Lifesciences

Eiko Lifesciences FAQs

Eiko Lifesciences share price is ₹45 As on 05 September, 2026 | 08:13

The Market Cap of Eiko Lifesciences is ₹62.3 Cr As on 05 September, 2026 | 08:13

The P/E ratio of Eiko Lifesciences is 12.7 As on 05 September, 2026 | 08:13

The PB ratio of Eiko Lifesciences is 0.9 As on 05 September, 2026 | 08:13

The 52 week High & Low of Eiko Lifesciences is ₹64.4/₹44.8 respectively As on 05 September, 2026 | 08:13

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23